Literature DB >> 12935351

Lipopolysaccharide of Burkholderia cepacia complex.

Arlene D Vinion-Dubiel1, Joanna B Goldberg.   

Abstract

Burkholderia cepacia complex (Bcc) is a group of phenotypically similar, genetically distinct bacteria that are beneficial to the environment but can also cause severe human infections. Bcc are being exploited for use as bioremediation agents and as a way to combat agricultural plant diseases. However, Bcc can cause lung infections in patients with chronic granulomatous disease or cystic fibrosis often resulting in mortality of these patients. Since it is unclear what bacterial components are necessary for causing human infections, studies of Bcc have focused on identifying putative virulence factors. As in other Gram-negative bacteria, the lipopolysaccharide (LPS) of Bcc induces a strong immune response that can contribute to host cell damage. The unusual structure of Bcc LPS lowers the anionic charge of the Bcc cell surface, which inhibits the binding and subsequent effects of cationic antibiotics. These distinguishing features include the substitution of a Ko for a Kdo residue in the inner core oligosaccharide and Ara4N residues bound to phosphates of the lipid A backbone. The structures of O antigen subunits and the consequent serotypes will also be discussed, with particular reference to the O antigen biosynthetic loci of two Bcc strains.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12935351     DOI: 10.1179/096805103225001404

Source DB:  PubMed          Journal:  J Endotoxin Res        ISSN: 0968-0519


  25 in total

1.  Correlation of wbiI genotype, serotype, and isolate source within species of the Burkholderia cepacia complex.

Authors:  Arlene D Vinion-Dubiel; Theodore Spilker; Charles R Dean; Henri Monteil; John J LiPuma; Joanna B Goldberg
Journal:  J Clin Microbiol       Date:  2004-09       Impact factor: 5.948

2.  Permeability Barrier of Gram-Negative Cell Envelopes and Approaches To Bypass It.

Authors:  Helen I Zgurskaya; Cesar A Löpez; S Gnanakaran
Journal:  ACS Infect Dis       Date:  2015       Impact factor: 5.084

3.  A hybrid cationic peptide composed of human β-defensin-1 and humanized θ-defensin sequences exhibits salt-resistant antimicrobial activity.

Authors:  Sudar Olli; Ramakrishnan Nagaraj; Swapna R Motukupally
Journal:  Antimicrob Agents Chemother       Date:  2014-10-27       Impact factor: 5.191

4.  Efficient Synthesis of 4-Amino-4-deoxy-L-arabinose and Spacer-equipped 4-Amino-4-deoxy-L-arabinopyranosides by Transglycosylation Reactions.

Authors:  Bernhard Müller; Markus Blaukopf; Andreas Hofinger; Alla Zamyatina; Helmut Brade; Paul Kosma
Journal:  Synthesis (Stuttg)       Date:  2010-09       Impact factor: 3.157

5.  Dioxygenases in Burkholderia ambifaria and Yersinia pestis that hydroxylate the outer Kdo unit of lipopolysaccharide.

Authors:  Hak Suk Chung; Christian R H Raetz
Journal:  Proc Natl Acad Sci U S A       Date:  2010-12-22       Impact factor: 11.205

Review 6.  Permeability barriers of Gram-negative pathogens.

Authors:  Helen I Zgurskaya; Valentin V Rybenkov
Journal:  Ann N Y Acad Sci       Date:  2019-06-04       Impact factor: 5.691

7.  Aerosol phage therapy efficacy in Burkholderia cepacia complex respiratory infections.

Authors:  Diana D Semler; Amanda D Goudie; Warren H Finlay; Jonathan J Dennis
Journal:  Antimicrob Agents Chemother       Date:  2014-05-05       Impact factor: 5.191

8.  Synthesis of Lipid A and Inner Core LPS ligands containing 4-amino-4-deoxy-l-arabinose units.

Authors:  Alla Zamyatina; Ralph Hollaus; Markus Blaukopf; Paul Kosma
Journal:  Pure Appl Chem       Date:  2011-11-19       Impact factor: 2.453

Review 9.  Extreme antimicrobial peptide and polymyxin B resistance in the genus Burkholderia.

Authors:  Slade A Loutet; Miguel A Valvano
Journal:  Front Cell Infect Microbiol       Date:  2011-07-22       Impact factor: 5.293

10.  Synthesis of Neoglycoconjugates Containing 4-Amino-4-deoxy-l-arabinose Epitopes Corresponding to the Inner Core of Burkholderia and Proteus Lipopolysaccharides.

Authors:  Markus Blaukopf; Bernhard Müller; Andreas Hofinger; Paul Kosma
Journal:  European J Org Chem       Date:  2011-11-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.